Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease

The introduction of tumor necrosis factor (TNF) inhibitors has significantly changed the treatment landscape in Crohn’s disease (CD). The overall therapeutic achievements with TNF inhibitors such as infliximab, adalimumab, and certolizumab pegol paved the way to push the boundaries of treatment goal...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Inflamm Bowel Dis
Hoofdauteurs: Reinisch, Walter, Gecse, Krisztina, Halfvarson, Jonas, Irving, Peter M, Jahnsen, Jørgen, Peyrin-Biroulet, Laurent, Rogler, Gerhard, Schreiber, Stefan, Danese, Silvio
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2020
Onderwerpen:
Clinical Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7737159/
https://ncbi.nlm.nih.gov/pubmed/32634212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izaa078
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items